fosinopril has been researched along with angiotensin ii in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (23.53) | 18.2507 |
2000's | 11 (64.71) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ford, NF; Fulmor, IE; Hui, KK; Natarajan, C; Smith, RA | 1 |
Fang, TC; Huang, WC | 1 |
Azizi, M; Guyene, TT; Mangold, B; Massien, C; Ménard, J; Vesterqvist, O | 1 |
Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
Cukon, S; Ennezat, PV; Hammer, A; Infeld, J; Jorde, UP; Le Jemtel, TH; Lisker, J; Sonnenblick, EH; Suryadevara, V | 1 |
Liang, X; Su, M; Xie, X; Yu, G; Zhao, S | 1 |
Maniu, CV; Meyer, DM; Redfield, MM | 1 |
Liang, X; Sun, M; Xie, X; Yang, T; Yu, G; Zhao, S | 1 |
He, BX; Liang, XQ; Yu, GL | 1 |
Berezin, AE | 1 |
Dang, XQ; He, QN; He, XJ; Li, Z; Wu, XC; Yi, Z | 1 |
Duan, SB; Jiang, WL; Li, J; Li, YJ; Liu, FY; Liu, YH; Peng, YM; Wang, YH; Xu, XQ; Zou, Q | 1 |
Guan, YF; Shen, FM; Su, DF; Tao, X; Zhang, YJ | 1 |
Asselbergs, FW; Hillege, HL; van der Harst, P; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
Ma, Q; Ning, Y; Sun, M; Wu, S; Yang, L; Yang, T | 1 |
Lin, S; Peng, W; Tang, R; Veeraragoo, P; Wu, R; Zhou, Q | 1 |
Chen, DJ; Li, WN; Lin, SD; Zhan, F; Zhou, QL | 1 |
4 trial(s) available for fosinopril and angiotensin ii
Article | Year |
---|---|
Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans.
Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Fosinopril; Humans; Male; Neprilysin; Pyridines; Reference Values; Renin; Thiazepines; Time Factors | 1999 |
Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Child; Drug Resistance; Drug Therapy, Combination; Female; Fosinopril; Glucocorticoids; Humans; Male; Nephrotic Syndrome; Peptidyl-Dipeptidase A; Prednisolone; Proteinuria; Renin | 2006 |
Effect of fosinopril treatment on serum C-reactive protein levels in patients with microalbuminuria.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; C-Reactive Protein; Double-Blind Method; Female; Fosinopril; Humans; Inflammation; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Sex Factors | 2008 |
[Plasma tissue factor and serum angiotensin II and the therapeutic effect of different dosages of fosinopril on chronic heart failure].
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Thromboplastin | 2009 |
13 other study(ies) available for fosinopril and angiotensin ii
Article | Year |
---|---|
Invasive pharmacodynamics of fosinopril in patients with congestive heart failure.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Chromatography, High Pressure Liquid; Female; Fosinopril; Half-Life; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulmonary Wedge Pressure; Renin | 1995 |
Role of angiotensin II in hyperinsulinemia-induced hypertension in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Chronic Disease; Fosinopril; Hyperinsulinism; Hypertension; Insulin; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley | 1998 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Fosinopril; Heart Failure; Humans; Lisinopril; Male; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Treatment Failure; Valine; Valsartan | 2000 |
Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats.
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; China; Disease Models, Animal; Fosinopril; Heart Ventricles; Hypertrophy, Left Ventricular; Losartan; Models, Cardiovascular; Myocardium; Random Allocation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1 | 2001 |
Hemodynamic and humoral effects of vasopeptidase inhibition in canine hypertension.
Topics: Adrenomedullin; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Dogs; Fosinopril; Hemodynamics; Hypertension; Kinetics; Male; Neprilysin; Peptides; Protease Inhibitors; Pyridines; Thiazepines; Vasoconstrictor Agents | 2002 |
Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Fibrosis; Fosinopril; Hypertension; Hypertrophy, Left Ventricular; Losartan; Myocardium; Rats; Rats, Inbred SHR | 2002 |
[Effects of lorsartan, fosinopril on myocardial fibrosis, angiotensin II and cardiac remolding in hypertensive rats].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Fibrosis; Fosinopril; Hypertension; Losartan; Male; Myocardium; Random Allocation; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2001 |
[Effect of fosinopril on the rate of neurohumoral and proinflammatory activation in patients with heart failure].
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Data Interpretation, Statistical; Echocardiography; Fosinopril; Heart Failure; Humans; Immunoenzyme Techniques; Middle Aged; Natriuretic Peptide, Brain; Radioimmunoassay; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
[Nephrotoxicity of high- and low-osmolar contrast media: Protective role of fosinopril or telmisartan in a rat model].
Topics: Angiotensin II; Animals; Apoptosis; Benzimidazoles; Benzoates; Caspase 3; Claudin-1; Contrast Media; Creatinine; Female; Fosinopril; Kidney; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Telmisartan | 2007 |
Fosinopril prevents the pulmonary arterial remodeling in sinoaortic-denervated rats by regulating phosphodiesterase.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Cyclic GMP; Denervation; Fosinopril; Gene Expression Regulation; Male; Nitric Oxide Synthase Type III; Phosphoric Diester Hydrolases; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2008 |
Role of Fosinopril and Valsartan on Klotho Gene Expression Induced by Angiotensin II in Rat Renal Tubular Epithelial Cells.
Topics: Angiotensin II; Animals; Cell Line; Epithelial Cells; Fosinopril; Gene Expression Regulation; Glucuronidase; Kidney Tubules; Klotho Proteins; Rats; Tetrazoles; Valine; Valsartan | 2010 |
[Fosinopril up-regulates and ameliorates the Ang II induced down-expression of klotho gene in NRK-52E].
Topics: Angiotensin II; Animals; Cells, Cultured; Down-Regulation; Epithelial Cells; Fosinopril; Gene Expression; Glucuronidase; Kidney Tubules; Klotho Proteins; Rats; RNA, Messenger | 2010 |